Call for Abstract
Scientific Program
Pharma Middle East, will be organized around the theme “Conscientious awareness of Pharmacists & Pharmaceutical sciences”
Pharma Middle East 2015 is comprised of 13 tracks and 63 sessions designed to offer comprehensive sessions that address current issues in Pharma Middle East 2015.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 3-1Drugs from natural sources
- Track 3-2Computational chemistry
- Track 3-3Structure aided and computer aided drug design
- Track 3-4Molecular drug design
- Track 3-5Telemedicine
- Track 3-6Protein structure prediction and molecular simulation
- Track 3-7Biochemistry
- Track 3-8Exploratory development
- Track 3-9Protein structure prediction and molecular simulation and etc.....
- Track 3-10Phytotherapy & Complementary medicine
- Track 5-1Regulations and organizations
- Track 5-2Clinical Pharmacy Services: patient compliance
- Track 5-3Health care management and providers
- Track 5-4Implimentation of pharmacogenetics in USA
- Track 5-5Drug safety
- Track 5-6Drug rediscovery
- Track 5-7Pharmaceutical services
- Track 5-8Role of pharmacists
- Track 5-9Halal medication
- Track 5-10Multiple drug use
- Track 5-11Online pharmacies
- Track 5-12Good governance in pharmacy and etc.......
- Track 6-1Drug discovery and development
- Track 6-2Industrial pharmaceutics
- Track 6-3Pre-clinical studies
- Track 6-4Clinical studies
- Track 6-5Supply chain
- Track 6-6Waste management
- Track 6-7Product management
- Track 6-8Post- marketing surveillance
- Track 6-9Good manufacturing practices
- Track 6-10Marketing
- Track 7-1Genomics and proteomics in Pharmaceutical Industry
- Track 7-2Clinical engineering in Pharmaceutical Industry
- Track 7-3Tissue engineering in Pharmaceutical Industry
- Track 7-4Identification and classification of genes
- Track 7-5Bio-engineering in Pharmaceutical Industry
- Track 7-6Engineering models in biomedicine
- Track 7-7Bionic human
- Track 7-8Clinical laboratory sciences
- Track 7-9Biomedical data engineering and etc......
- Track 8-1FDCA
- Track 8-2NDA
- Track 8-3Adulteration
- Track 8-4Misbranding
- Track 8-5Exemption in prescription
- Track 8-6Experimental animal ethics
- Track 8-7Human trial ethics and etc....
- Track 9-1Material characterisation - chemical and physical
- Track 9-2Morphic form identification
- Track 9-3Salt selection
- Track 9-4Compressibility testing
- Track 9-5Excipient and Process compatibility testing and etc....
- Track 11-1Drug interactions and adverse drug reactions
- Track 11-2Role of clinical pharmacist
- Track 11-3Clinical pharmacy and its key role in treatment
- Track 11-4Clinical drug development and therapeutics
- Track 11-5Clinical molecular genetics
- Track 11-6Clinical Immunology
- Track 11-7Pharmacoepidimiology and Pharmacotherapy
- Track 11-8Pharmacy Practice and Pharmacoeconomy
- Track 11-9Advances in Clinical Pharmacy
- Track 11-10Research methodology and recent updates on clinical trials